• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

ImmunoCellular Therapeutics Names New CEO

Article

December 16, 2016

ImmunoCellular Therapeutics (Los Angeles, CA) announced that its Board of Directors has appointed Anthony Gringeri, Ph.D, as Chief Executive Officer.   The appointment follows the decision by Andrew Gengos to resign the position of CEO. Mr. Gengos will continue to play an active role with the company as a member of the Board of Directors, the company reports.   Dr. Gringeri has served as ImmunoCellular's Senior Vice President of Strategic Resources since August 2013. He joined ImmunoCellular from ViaCyte, where he was Vice President and Chief Development Officer. He previously served as Chief Operating Officer for Amsterdam Molecular Therapeutics.

Recent Videos
Related Content
Rudy Kuhn

The Future of Digital Twins: Q&A with Rudy Kuhn

Mike Hollan
July 25th 2024
Article

The lead transformation evangelist at Celonis discusses how digital twins are becoming more prominent in the pharma industry.

Fitterfly

Fitterfly Announces Home Digital Therapeutic That Uses AI to Analyze Images of Meals

Mike Hollan
July 22nd 2024
Article

The AI-powered feature will provide detailed nutritional information based on photos of food taken by users.

Abid Rahman

AI’s Role in Drug Launches, Operations, and Drug Pricing: Q&A with Abid Rahman

Mike Hollan
July 16th 2024
Article

EVERSANA’s senior vice president of innovation discusses how the technology has been implemented in various areas of the pharmaceutical industry.

Dea Belazi

Transforming Patient Care Management: Q&A with Dea Belazi

Mike Hollan
July 12th 2024
Article

The AscellaHealth CEO discusses how new technologies are increasing the options in patient care.

Dr. Jo Varshney

Artificially Discovering New Molecules and Indications: Q&A with Dr. Jo Varshney

Mike Hollan
July 11th 2024
Article

Dr. Varshney discusses how AI is being used to sort data and discover new molecules and indications for existing drugs.

Jon Koch, CEO, Avalere Health.

Can Data and AI Deliver Whole-Person Health?

Jon Koch
July 9th 2024
Article

Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.